NDST2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.149400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.182600E-01
Normal-vs-Stage2
3.143600E-01
Normal-vs-Stage3
2.478800E-01
Normal-vs-Stage4
2.304800E-01
Stage1-vs-Stage2
9.673200E-01
Stage1-vs-Stage3
3.242000E-01
Stage1-vs-Stage4
9.161800E-01
Stage2-vs-Stage3
2.403400E-01
Stage2-vs-Stage4
9.022000E-01
Stage3-vs-Stage4
4.555000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.155200E-01
Normal-vs-AfricanAmerican
3.450000E-01
Normal-vs-Asian
2.857600E-01
Caucasian-vs-AfricanAmerican
6.772600E-01
Caucasian-vs-Asian
4.579000E-01
AfricanAmerican-vs-Asian
2.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.046200E-01
Normal-vs-Female
3.300800E-01
Male-vs-Female
2.520800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.583400E-01
Normal-vs-Age(41-60Yrs)
3.525000E-01
Normal-vs-Age(61-80Yrs)
3.009000E-01
Normal-vs-Age(81-100Yrs)
2.782000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.928600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.074600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.143620E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.270300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.682300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.473600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.807600E-01
Normal-vs-Daily Drinker
2.942400E-01
Normal-vs-Weekly Drinker
3.333200E-01
Normal-vs-Occasional Drinker
3.116000E-01
Normal-vs-Social Drinker
3.607800E-01
Non Drinker-vs-Daily Drinker
7.165800E-01
Non Drinker-vs-Weekly Drinker
2.897200E-01
Non Drinker-vs-Occasional Drinker
4.859400E-01
Non Drinker-vs-Social Drinker
1.248420E-01
Daily Drinker-vs-Weekly Drinker
3.724000E-01
Daily Drinker-vs-Occasional Drinker
6.777200E-01
Daily Drinker-vs-Social Drinker
1.545420E-01
Weekly Drinker-vs-Occasional Drinker
6.514200E-01
Weekly Drinker-vs-Social Drinker
6.104800E-01
Occasional Drinker-vs-Social Drinker
3.408200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.952000E-01
Normal-vs-Grade 2
9.395200E-01
Normal-vs-Grade 3
9.413200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.713000E-01
Grade 1-vs-Grade 3
7.617000E-01
Grade 1-vs-Grade 4
7.952000E-01
Grade 2-vs-Grade 3
9.697800E-01
Grade 2-vs-Grade 4
9.395200E-01
Grade 3-vs-Grade 4
9.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.124400E-01
Normal-vs-NonDiabetic
2.996600E-01
Diabetic-vs-NonDiabetic
6.238000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.152200E-01
Normal-vs-NoPancreatitis
3.048200E-01
Pancreatitis-vs-NoPancreatitis
8.471400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.249000E-01
Normal-vs-N1
3.088600E-01
N0-vs-N1
5.379000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.353600E-01
Normal-vs-TP53-NonMutant
3.185000E-01
TP53-Mutant-vs-TP53-NonMutant
4.837400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
